4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001915598-26-000005
Chief Commercial Officer sold 1,085 shares at an average $23.42 ($25,408)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedl-Naderer Johanna · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-04 | Sale : show line 1 in the form 10b5-1 | −900 | $24.35 | $21,915 | 153,082 | D |
| 2026-09-08 | Sale : show line 2 in the form 10b5-1 | −185 | $18.88 | $3,493 | 152,897 | D |
| Open-market sales · 1,085 sh · avg $23.42 · $25,408 | ||||||
Loading xslF345X06/ownership.xml…